'Tb patients' presentation slideshows

NEUROLOGICAL TUBERCULOSIS Presented By : Dr. Shiyas Mohammed JR. Pulmonary Medicine

NEUROLOGICAL TUBERCULOSIS Presented By : Dr. Shiyas Mohammed JR. Pulmonary Medicine. NEUROLOGICAL TB Neurological TB comprises 5-10% of extrapulmonary TB and is increasing globally due to HIV-TB co-infection. CLASSIFICATION

1.05k views • 73 slides

23 APRIL 2013

592 views • 50 slides

Drug Resistant Tuberculosis (DR-TB): An Update

Drug Resistant Tuberculosis (DR-TB): An Update . Dr. Dick Menzies Montreal Chest Institute. Definitions. Primary DR: Resistance in person treated <1 month or not at all Acquired DR: Resistance in person treated > 1 month Mono-drug resistance: Resistance to 1 drug

957 views • 49 slides

TB/HIV Integration at ICAP-Supported Health Facilities

TB/HIV Integration at ICAP-Supported Health Facilities. ICAP Data Dissemination Meeting March 4 2008 Andrea Howard and Suzue Saito. Outline. Background and rationale for TB/HIV integration Review of TB screening questionnaire Quarterly reported data on TB screening in HIV care settings

659 views • 47 slides

2013 Expert Panel New Practice Recommendations Nancy Baruch, RN, MBA

2013 Expert Panel New Practice Recommendations Nancy Baruch, RN, MBA Center for TB Control and Prevention Maryland Department of Health and Mental Hygiene Prevention and Health Promotion Administration.

744 views • 43 slides

Iryna Reshevska Catherine Severo Melinda Ojermark Mark Eldon-Edington

with the Global Fund to Fight AIDS,TB and Malaria. Global Fund Country Coordinating Mechanisms: Providing Oversight and Leadership during the Transitional Funding Period. Iryna Reshevska Catherine Severo Melinda Ojermark Mark Eldon-Edington. XIX International AIDS Conference 2012

451 views • 34 slides

Revised National TB Control Programme

Revised National TB Control Programme. DD/ DHO / CS meeting Date: 23-24 May 2014 Dr Manohar Pawar (Jt. Director, Tuberculosis and Leprosy). Content. Objectives of RNTCP Maharashtra Performance: Case Finding and Case Holding Nikshay TB Notification Finance .

946 views • 31 slides

Overview of PAL strategy

Overview of PAL strategy. Salah-Eddine Ottmani, MD, MPH TB Strategy and Operations Unit Stop TB Department WHO, Geneva Workshop on TB proposal preparation for Round 6 of the Global Fund to fight AIDS, TB and Malaria Geneva, 15 - 18 May 2006.

418 views • 22 slides

Chairperson: Dr. Satya Ranjan Sutradhar FCPS (Medicine), MD (Endocrinology)

Tuberculosis burden in households of patients with multi drug-resistant and extensively drug-resistant tuberculosis: a retrospective cohort study. Chairperson: Dr. Satya Ranjan Sutradhar FCPS (Medicine), MD (Endocrinology) Associate professor and Head Department of Medicine

434 views • 21 slides

Chapter 10: Restricting antibiotic use and optimizing dosing

Chapter 10: Restricting antibiotic use and optimizing dosing. Antibiotic resistance factors. The two factors affecting antibiotic resistance: Amount of antibiotic used How we use it

310 views • 16 slides

Engaging Chemists to Strengthen TB Notification

Engaging Chemists to Strengthen TB Notification. Background. 46% TB patients not known to National Programme > 80% of initial care-seeking is in private sector Based on prescriptions from informal health care providers anti-TB drugs was available over-the-counter

544 views • 14 slides

Paranaque IMRAD

381 views • 13 slides

Active Tuberculosis Disease 1993-2003

Active Tuberculosis Disease 1993-2003. Reported Tuberculosis Cases. Drug Resistant Tuberculosis. *Resistant to at least INH and Rifampin. Tuberculosis, Site of Disease. Reported Tuberculosis Cases by Gender. Wisconsin, 1999-2003. Age-distribution of TB Cases. Wisconsin, 2003.

191 views • 9 slides

The asymptomatic, sputum-negative TB patient: What does it mean for practice?

The asymptomatic, sputum-negative TB patient: What does it mean for practice?. Carl Abelardo T. Antonio , MD, MPH Asst. Prof. of Health Policy & Administration ctantoniomd@gmail.com.

225 views • 7 slides

Closing Remarks CPTR 2012 WORKSHOP

202 views • 6 slides

Tuberculosis - Drug Pipeline Analysis and Market Forecasts t

The Tuberculosis Drugs Market is Forecast to Decline Until 2016

471 views • 4 slides

Methods & Results

Integration of HIV and TB services results in earlier and more prioritised ART initiation in Uganda. Sabine Hermans 1,2,3 , Barbara Castelnuovo 1 , Andrew Kambugu 1 , Joep Lange 2 , Andy Hoepelman 3 , Yuka Manabe 1,4

129 views • 4 slides

Setting

Time and money: the cost of utilizing HIV and TB treatment and care in rural KwaZulu-Natal (poster #MOPDE0201). Setting

148 views • 3 slides

Facts at a glance HIV kills more than 6000 people every day worldwide.

Facts at a glance HIV kills more than 6000 people every day worldwide. Around 5000 people die from TB every day although TB is curable. After HIV, TB is the greatest infectious killer of young people and adults in the world today.

139 views • 1 slides

Discussion & Limitations

Burden of Serious Fungal Infections in Denmark. Maiken Cavling Arendrup 1 , Thomas Benfield 2 , David W. Denning 3.

84 views • 1 slides